A federal judge allowed lawsuits to move ahead alleging that taking Tylenol while pregnant increases the risks of a child being diagnosed with autism or ADHD.
On Thursday, U.S. District Judge Denise Cote, in the Southern District of New York, denied Johnson & Johnson’s motion, which insisted that U.S. Food and Drug Administration regulations preempted claims that it failed to warn of Tylenol’s prenatal risks. Cote found Johnson & Johnson could add to Tylenol’s warning label, which advises women who are pregnant or breastfeeding to “ask a health professional before use.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
